During the past decade, Fresno Cancer Center conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 7 clinical trials were completed, i.e. on average, 14.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 7 clinical trials were completed. i.e. 38.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fresno Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 20 trials, followed by "NRG Oncology" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fresno Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 33 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Fresno Cancer Center" are "Stage II Breast Cancer" (4 trials), "Stage IIIA Breast Cancer" (4 trials), "Invasive Breast Carcinoma" (3 trials), "Stage IIA Breast Cancer" (3 trials) and "Stage IIB Breast Cancer" (3 trials). Many other conditions were trialed in "Fresno Cancer Center" in a lesser frequency.

Most popular intervention types in "Fresno Cancer Center" are "Drug" (37 trials), "Other" (32 trials), "Biological" (19 trials), "Radiation" (19 trials) and "Procedure" (18 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (15 trials), "Laboratory Biomarker Analysis" (12 trials), "Nivolumab" (10 trials), "Questionnaire Administration" (10 trials) and "Biospecimen Collection" (7 trials). Other intervention names were less common.

The vast majority of trials in "Fresno Cancer Center" are 44 trials for "All" genders, 6 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Fresno Cancer Center". undefined are not yet recruiting, 17 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Fresno Cancer Center, 4 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fresno Cancer Center, 1 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Fresno Cancer Center has several departments that took part in Clinical trials: "Rohnert Park Cancer Center" - 84 trials, "South Sacramento Cancer Center" - 72 trials